Novakand Pharma AB (publ) (FRA:3EE0)

Novakand Pharma AB Statistics

Total Valuation

FRA:3EE0 has a market cap or net worth of EUR 1.96 million. The enterprise value is -72,131.

Market Cap	1.96M
Enterprise Value	-72,131

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	121.19M
Shares Outstanding	n/a
Shares Change (YoY)	+17.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.93%
Owned by Institutions (%)	16.11%
Float	111.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.08
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.34

Current Ratio	7.34
Quick Ratio	7.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -112.87% and return on invested capital (ROIC) is -46.88%.

Return on Equity (ROE)	-112.87%
Return on Assets (ROA)	-42.81%
Return on Invested Capital (ROIC)	-46.88%
Return on Capital Employed (ROCE)	-172.20%
Revenue Per Employee	n/a
Profits Per Employee	-938,898
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-99.86%
50-Day Moving Average	0.00
200-Day Moving Average	0.07
Relative Strength Index (RSI)	44.32
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.12M
Pretax Income	-4.69M
Net Income	-4.69M
EBITDA	n/a
EBIT	-3.12M
Earnings Per Share (EPS)	-0.04

Balance Sheet

The company has 2.01 million in cash and n/a in debt, giving a net cash position of 2.01 million.

Cash & Cash Equivalents	2.01M
Total Debt	n/a
Net Cash	2.01M
Net Cash Per Share	n/a
Equity (Book Value)	1.81M
Book Value Per Share	0.01
Working Capital	1.81M

Cash Flow

Operating Cash Flow	-3.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:3EE0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.04%
Shareholder Yield	-17.04%
Earnings Yield	-239.97%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 24, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Feb 24, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1